Levamisole Hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Levamisole Hydrochloride

Search keywords :
Levamisole

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Immunomodulators

First Approval Country :
Mainland China

First Approval Date Filter:
1981

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Institut De Recherche Pour Le Developpement

Active Indication_Name:
Warts

In Active Indication_Name:
Colonic Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ficlatuzumab Description
CD147 Rabbit pAb References
DXd Antibody (YA897): DXd Antibody (YA897) is an unconjugated, mouse-derived, anti-DXd (YA897) monoclonal antibody. DXd Antibody (YA897) can be used for: ELISA expriments in species-independent background without labeling.

Author: Interleukin Related

Related Posts